Company intelligence / Profile preview

Posit Science

San Francisco, California, United Statesbrainhq.com ↗

Ownership: Private
Development stage: Commercial

Overview

Posit Science’s BrainHQ platform has been evaluated in over 300 studies, including blinded, randomized controlled trials. These studies have shown improvements in standard measures of cognition (speed, attention, memory), quality of life metrics (functional independence, mood), and real-world activities such as driving and workplace performance. Recent research also suggests benefits for people experiencing cognitive symptoms from Long COVID[4][7].

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapyDevice (digital cognitive training platform)
Industry: Digital Health Medical Devices

Partnerships

U.S. Department of DefenseNational Institutes of HealthGroup Health Cooperative

Beyond the preview

Go deeper on Posit Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Posit Science.

Explore the full profile